Insights & Publications
© 2018 Debevoise & Plimpton LLP
New Public and Private Efforts to Contain Healthcare Costs: What it Means for the Healthcare Industry
20 December 2017
View Client Update
As healthcare costs continue to climb, both public and private payors are pursuing strategies to expand access and contain costs.
The FDA and state governments have recently announced initiatives that are aimed at directly or indirectly reducing prescription drug costs.
Healthcare companies are using vertical integration as a means of controlling costs and developing new means of providing reasonably-priced, accessible healthcare.
These initiatives provide strategic opportunities for healthcare companies that can enhance the efficacy and cost-effectiveness of healthcare goods and services.
Mergers & Acquisitions
Andrew L. Bab
Jennifer L. Chu
Mark P. Goodman
Maura Kathleen Monaghan
View More Authors
How Life Sciences Cos. Can Prepare For Legal And PR Crises
Debevoise Advises 4Refuel and Its Equityholders in the Sale of 4Refuel to Finning International
Debevoise and the City of New York: Standing Up for Immigrants—and the Constitution
Medical Device Cybersecurity Report Advancing Coordinated Vulnerability Disclosure
UK Modern Slavery Act Transparency Statement
Debevoise Women's Review